Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ENTA is expected to report earnings to rise 10.48% to -115 cents per share on May 12

Enanta Pharmaceuticals ENTA Stock Earnings Reports

Q1'25

Est.

$-1.16

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.20

Q2'24

Beat

by $0.36

Q1'24

Missed

by $0.13

The last earnings report on February 10 showed earnings per share of -104 cents, beating the estimate of -126 cents. With 196.86K shares outstanding, the current market capitalization sits at 165.97M.

View a ticker or compare two or three

Compare

ENTA